Inventor · disambiguated record
Sachin Chandran
Also filed as: CHANDRAN SACHIN · CHANDRAN SACHIN S
6 granted patents·1 pending application·63 citations·filing 2008–2021
82Inventor score
Top patents by PatentIndex Score
7 records- 0194US10980746B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2018·Granted Apr 20, 2021·13 cites·25 claims
- 0293US10206877B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2015·Granted Feb 19, 2019·29 cites·27 claims
- 0392US11951212B2Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseasesVERTEX PHARMA·Filed 2021·Granted Apr 9, 2024·3 cites·37 claims
- 0487US9422234B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerCHANDRAN SACHIN S·Filed 2008·Granted Aug 23, 2016·14 cites·26 claims
- 0585US10369113B2Prostate specific membrane antigen (PSMA) targeted nanoparticles for therapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2016·Granted Aug 6, 2019·4 cites·19 claims
- 0652US2020170960A1Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancerUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 0729US8252821B2Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compoundCHANDRAN SACHIN·Filed 2010·Granted Aug 28, 2012·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Sachin Chandran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →